Tags: Chemical Compound, Chemical Substance.
SQ109 is a drug undergoing development for treatment of tuberculosis.On October 16th 2007 it was given the status of Orphan drug by the U.S. Food and Drug Administration (FDA) for use against drug-susceptible and drug-resistant TB bacteria.SQ109 completed three phase I studies in the U.S. and one Phase II efficacy studies in tuberculosis patients in Africa.
